Starting treatment: latest news

Starting treatment resources

Starting treatment features

Starting treatment in your own words

Starting treatment news from aidsmap

More news

Starting treatment news selected from other sources

  • New START Data Fill in When to Start ART, Now the Question is How

    It's critical to recognize that figuring out when to start is only part of the puzzle. The question of how to start is equally critical and isn’t going to be settled by any randomized trial. The how concerns the environment in which individuals are offered treatment, the services that are part of that offer—peer support, community-based refills, non-biased provider care, among others—and the ways that the decision to start is framed.

    29 May 2015 | AVAC
  • START findings highlight treatment divide

    The START data show that basing treatment initiation on immune cell count is a form of rationing. But whether, how soon, and even how the findings will change clinical practice is another question.

    28 May 2015 | Science Speaks
  • UNAIDS welcomes further evidence that starting antiretroviral therapy early saves lives

    “Every person living with HIV should have immediate access to life-saving antiretroviral therapy,” said Michel Sidibé, Executive Director of UNAIDS. “Delaying access to HIV treatment under any pretext is denying the right to health.”

    28 May 2015 | UNAIDS
  • i-Base Q&A on the START study results

    On 27 May 2015, early results showed that the early treatment group did better. One of the surprises is that even at very high CD4 counts, treatment reduces the risk of HIV related illnesses.

    28 May 2015 | HIV i-Base
  • HIV Treatment Guidelines Nix Atripla as First-Line Therapy

    A revision of U.S. HIV treatment guidelines has removed Atripla (efavirenz/tenofovir/emtricitabine) from the priority list of first-line antiretrovirals.

    09 April 2015 | AIDSMeds
  • Early HIV treatment and isoniazid prophylaxis: why TEMPRANO results do not yet support universal ART at CD4 >500 cells/mm3

    The TEMPRANO study presented as a late breaker oral presentation, included important information for timing of TB prophylaxis and the timing of ART in TB-endemic countries. The conclusions though do not support universally starting treatment at CD4 counts >500 or answer the primary question of the international START study.

    03 March 2015 | HIV i-Base
  • Inflammation Persists Despite Very Early HIV Treatment

    Biomarkers of inflammation increase during acute HIV infection and remain elevated despite early suppressive antiretroviral therapy, according to a study presented at CROI 2015, in Seattle, Washington.

    27 February 2015 | The Body Pro
  • HIV Positive Guys Need To Consider Going On Meds Earlier — ACON

    MORE HIV-positive men need to think about starting treatment straight after diagnosis if ambitious targets to end HIV transmission by 2020 are to be met, the head of New South Wales based LGBTI health body ACON has said. The comments come as the organisation launches a major new sexual health campaign that also aims to clear up confusion surrounding one of the newest buzzwords in the HIV lexicon: "undetectable".

    23 February 2015 | Star Observer
  • The Search for a Permanent Alternative to HIV Drugs

    Researchers Carefully Tailor a Study to Find Patients to Test Going Off Antiretroviral Medication

    16 February 2015 | Wall Street Journal
  • HIV Organizations Urge Continuation of D:A:D Study

    D:A:D follows 50,000 HIV-positive people, looking at drug safety and side effects over time. Results from D:A:D have changed HIV treatment guidelines, and how HIV-positive people are treated by their health care providers. We urge pharmaceutical companies to continue funding this vital study.

    11 February 2015 | Treatment Action Group
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.